EV/EBITDA:
7.47+0.28(+3.89%)Summary
- As of today, CPRX EV/EBITDA is 7.47, with a rise of +0.28 (+3.89%) during the most recent trading session on December 12, 2025.
- Over the past year, CPRX EV/EBITDA has dropped by -2.48 (-24.92%).
- CPRX EV/EBITDA is now -86.85% below its all-time high of 56.79.
Performance
CPRX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
CPRX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | +3.9% | +3.9% | +3.0% |
| 1M1 Month | +4.9% | +4.9% | +3.7% |
| 3M3 Months | +17.1% | +23.5% | +18.3% |
| 6M6 Months | -15.6% | -7.1% | -2.8% |
| YTDYTD | -13.2% | +10.3% | +13.2% |
| 1Y1 Year | -24.9% | +5.2% | +10.7% |
| 5Y5 Years | +24.7% | +789.1% | +550.7% |
CPRX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | 7.47 | at high | 7.01 | +6.6% |
| 3M | 3-Month | 7.47 | at high | 5.87 | +27.3% |
| 6M | 6-Month | 8.85 | -15.6% | 5.87 | +27.3% |
| 1Y | 1-Year | 11.20 | -33.3% | 5.87 | +27.3% |
| 3Y | 3-Year | 20.98 | -64.4% | 5.87 | +27.3% |
| 5Y | 5-Year | 20.98 | -64.4% | 4.89 | +52.8% |
| All-Time | All-Time | 56.79 | -86.8% | -54.25 | +113.8% |
CPRX EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 7.47(-13.2%) |
| 2024 | 8.61(-38.1%) |
| 2023 | 13.90(-13.7%) |
| 2022 | 16.10(+66.8%) |
| 2021 | 9.65(+97.3%) |
| 2020 | 4.89(-46.9%) |
| 2019 | 9.21(+325.7%) |
| 2018 | -4.08(+76.0%) |
| 2017 | -17.01(-600.0%) |
| Date | Value |
|---|---|
| 2016 | -2.43(+65.8%) |
| 2015 | -7.10(+37.7%) |
| 2014 | -11.40(-43.4%) |
| 2013 | -7.95(-1372.2%) |
| 2012 | -0.54(+87.4%) |
| 2011 | -4.28(-39.9%) |
| 2010 | -3.06(-524.5%) |
| 2009 | -0.49(+60.8%) |
| 2008 | -1.25(+77.0%) |
| 2007 | -5.44 |
FAQ
- What is Catalyst Pharmaceuticals, Inc. EV/EBITDA?
- What is the all-time high EV/EBITDA for Catalyst Pharmaceuticals, Inc.?
- What is CPRX EV/EBITDA year-to-date change?
- What is Catalyst Pharmaceuticals, Inc. EV/EBITDA year-on-year change?
What is Catalyst Pharmaceuticals, Inc. EV/EBITDA?
The current EV/EBITDA of CPRX is 7.47
What is the all-time high EV/EBITDA for Catalyst Pharmaceuticals, Inc.?
Catalyst Pharmaceuticals, Inc. all-time high EV/EBITDA is 56.79
What is CPRX EV/EBITDA year-to-date change?
Catalyst Pharmaceuticals, Inc. EV/EBITDA has changed by -1.14 (-13.24%) since the beginning of the year
What is Catalyst Pharmaceuticals, Inc. EV/EBITDA year-on-year change?
Over the past year, CPRX EV/EBITDA has changed by -2.48 (-24.92%)